Delivery of a Nicotine Replacement Therapy Sample at Outdoor Smoking Hotspots for Promoting Quit Attempts: A Pilot Randomized Controlled Trial.

What Was Tested

This randomized controlled trial looks at Therapeutic nicotine (patch, non-peptide).

Risk ratios from log-binomial regression models were used to assess the associations.

Why It Was Studied

Outdoor smoking hotspots are convenient venues for promoting smoking cessation.

Who Took Part

By PubMed's age tags, the people studied were adults, both men and women.

This pilot parallel, single-blinded, two-group (1:1) randomized controlled trial proactively recruited adult smokers in outdoor smoking hotspots in Hong Kong.

How the Study Was Run

In design terms this was a randomized, single-blind, parallel-group and pilot study.

Because people in this Therapeutic nicotine (patch, non-peptide) study were split into groups at random, differences between the groups are less likely to reflect who happened to join each one.

Only one side, usually the participants, was kept unaware of whether Therapeutic nicotine (patch, non-peptide) was given.

Groups ran in parallel: each of the participants stayed in one arm throughout.

It is described as a pilot, a small early test of whether a larger Therapeutic nicotine (patch, non-peptide) study would be practical.

What Was Measured

The subject headings attached to it are Behavior Therapy, Health Behavior, Hong Kong, Nicotine, Pilot Projects, Smokers and Smoking Cessation.

What This Means in Plain Language

The paper is a randomized, single-blind and parallel-group study of Therapeutic nicotine (patch, non-peptide).

The abstract goes on to report its results in about 10 sentences; this page does not restate them, so read the paper for the findings and their limits.

The publication is from 2020 (Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco), a journal based in England.

More context: the Therapeutic nicotine (patch, non-peptide) compound page, all human trials.